These results showed that AIE@HFn-scfv could be efficiently enriched in the tumor area through the targeting effect of CD71 and Claudin18.2, and could effectively circumvent recruitment in the liver region and enhance circulation time in the peripheral blood. This evidence concerns the gene TFRC and neoplasm.